During the past decade, Rowan Regional Medical Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rowan Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 4 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "Children's Oncology Group" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rowan Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Rowan Regional Medical Center" are "Breast Carcinoma" (2 trials), "Recurrent Uterine Corpus Cancer" (2 trials), "ALK Gene Rearrangement" (1 trials), "ALK Gene Translocation" (1 trials) and "ALK Positive" (1 trials). Many other conditions were trialed in "Rowan Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Rowan Regional Medical Center" are "Drug" (14 trials), "Other" (10 trials), "Biological" (7 trials), "Procedure" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Computed Tomography" (3 trials), "Radiation Therapy" (3 trials), "Biopsy" (2 trials) and "Capivasertib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rowan Regional Medical Center" are 14 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rowan Regional Medical Center". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Rowan Regional Medical Center, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rowan Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".